EGFR 키나제 억제제로써의 아릴-인-산소 화합물

EGFR 키나제(EGFR kinase) 저해제로서 화학식 (I)에 나타나는 새로운 클래스의 아릴-인-산소 화합물, 및 그 약학적으로 허용되는 염이 개시된다. Disclosed is a class of new aryl-phosphorus-oxygen compounds as shown in formula (I) as EGFR kinase inhibitors, and pharmaceutically acceptable salts thereof....

Full description

Saved in:
Bibliographic Details
Main Authors CHEN SHUHUI, ZHAO LELE, HU LIHONG, HU GUOPING, LIU XILE, LI JIAN, ZHAO JUN, ZHAO NING, PAN WEI, WU LINGYUN, DING CHARLES Z
Format Patent
LanguageKorean
Published 25.03.2020
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:EGFR 키나제(EGFR kinase) 저해제로서 화학식 (I)에 나타나는 새로운 클래스의 아릴-인-산소 화합물, 및 그 약학적으로 허용되는 염이 개시된다. Disclosed is a class of new aryl-phosphorus-oxygen compounds as shown in formula (I) as EGFR kinase inhibitors, and pharmaceutically acceptable salts thereof.
Bibliography:Application Number: KR20207004522